Trial Profile
A Screening Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jul 2023
Price :
$35
*
At a glance
- Drugs Technetium Tc99m etarfolatide (Primary)
- Indications Renal cell carcinoma
- Focus Diagnostic use
- Sponsors Endocyte
- 05 Jun 2015 New trial record